The activist shareholder helped the UK insurer deliver cost cuts and release capital. Axa CEO Thomas Buberl has a similar ...

Novo Nordisk muscled in on Pfizer’s bid for US drugmaker Metsera with a $9 bln offer. The $226 bln Danish group is paying a ...

Shares of the $1.5 bln tinned fish maker Princes slipped after it priced at the bottom of the range. It adds to a dismal year ...

Persistent budget deficits have fuelled fears the US will monetise public debt of 114% of GDP. A simple hedge is to switch to ...

Apollo, KKR and others turbo-charged their credit divisions by selling annuities. It drove a surge in sales of the retirement ...

The Finnish group gained over 20%, or $7 bln, after the chip giant unveiled a $1 bln investment. But the partnership is not ...

The Russell 2000, an index tracking sub-$5 bln firms, is up 11% this year. Yet these diminutive strivers’ hopes of closing a valuation gap to larger rivals face profitability and growth woes. With ...

Microsoft, Alphabet and Meta spent another $60 bln combined in the quest to conquer machine learning. The Windows maker can ...

A court victory for minority shareholders of seized oil giant YPF now hangs in the balance. The US ruling upended sovereign debt norms by interpreting foreign law and ordering Buenos Aires to send the ...

The country’s new leader wants to revive former PM Shinzo Abe’s reflationary agenda when prices are already rising at 3% a ...

Skyworks and Qorvo, whose semiconductors power iPhones, unveiled a deal that caps years of prodding from pushy investor ...

ChatGPT’s parent has ditched its quirky structure, relaxing Microsoft’s exclusive grip. The tech giant gets 27% of the $500 ...